Home / Stocks / JANX

JANX insider trading

Janux Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$79.0M
Buys · last 90 days
0 · $0
Most recent buy
2025-03-07

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-03-07Kolchinsky Peter
Director · 10% owner
Bought824,041$30.75$25.3M
2024-12-27Campbell David Alan
President and CEO
Sold25,000$56.19$1.4M
2024-12-03Campbell David Alan
President and CEO
Sold15,000$67.00$1.0M
2024-10-22Kolchinsky Peter
Director · 10% owner
Bought1,200,000$44.75$53.7M
2024-10-18Avalon BioVentures I, LP
10% owner
Sold1,608,716$46.13$74.2M
2024-09-30Avalon BioVentures I, LP
10% owner
Sold275,255$46.96$12.9M
2024-09-27Meyer Andrew Hollman
Chief Business Officer
Sold50,000$45.96$2.3M
2024-09-12Avalon BioVentures I, LP
10% owner
Sold419,373$46.94$19.7M
2024-09-10Avalon BioVentures I, LP
10% owner
Sold219,009$42.00$9.2M

Most active insider buyers

InsiderRoleBuysTotal bought
Kolchinsky PeterDirector · 10% owner2$79.0M

See JANX on the chart

Every insider buy and sell for JANX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.